SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-137744
Filing Date
2023-05-08
Accepted
2023-05-08 08:51:30
Documents
15
Period of Report
2023-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d431837d8k.htm   iXBRL 8-K 28843
2 EX-1.1 d431837dex11.htm EX-1.1 171010
3 EX-5.1 d431837dex51.htm EX-5.1 9524
7 GRAPHIC g431837g0505232253644.jpg GRAPHIC 2623
  Complete submission text file 0001193125-23-137744.txt   389594

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA krys-20230508.xsd EX-101.SCH 2858
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20230508_lab.xml EX-101.LAB 17993
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20230508_pre.xml EX-101.PRE 11266
9 EXTRACTED XBRL INSTANCE DOCUMENT d431837d8k_htm.xml XML 3373
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 23896066
SIC: 2836 Biological Products, (No Diagnostic Substances)